慢性过敏性肺炎支气管肺泡灌洗液淋巴细胞增多的系统评价与荟萃分析
CHP的BALF淋巴细胞百分比合并估计值为42.8%(95%CI 37.7-47.8),显著高于特发性肺纤维化(IPF)的10.0%(95%CI 6.9-13.1,p<0.0001)。基于8项研究的个体患者数据,淋巴细胞百分比>20%诊断CHP的敏感性为68.1%、特异性为64.8%,但原始研究存在纳入偏倚风险。
要点
- CHP患者BALF淋巴细胞百分比合并估计为42.8%,显著高于IPF的10.0%。
- 淋巴细胞百分比>20%诊断CHP的敏感性68.1%、特异性64.8%。
- 更高阈值可提高特异性但降低敏感性,需结合临床综合判断。
核心结论
- CHP的BALF淋巴细胞百分比高于IPF和其他特发性间质性肺炎,但原始研究存在纳入偏倚风险,需前瞻性研究评估其附加鉴别价值。
主要发现
- CHP的BALF淋巴细胞百分比合并估计为42.8%(95%CI 37.7-47.8,I2=95.3%)。
- IPF为10.0%(95%CI 6.9-13.1,I2=91.2%),非IPF特发性间质性肺炎为23.1%(95%CI 3.0-43.2,I2=85.2%)。
- 结缔组织病相关间质性肺病为23.4%(95%CI 11.0-35.9,I2=45.7%),结节病为31.2%(95%CI 17.6-44.8,I2=95.2%)。
- CHP与IPF(p<0.0001)、非IPF特发性间质性肺炎(p=0.0309)差异显著,与结缔组织病相关间质性肺病(p=0.0824)和结节病(p=0.0966)差异不显著。
- 基于8项研究的个体患者数据,淋巴细胞百分比>20%诊断CHP的敏感性为68.1%、特异性为64.8%,更高阈值敏感性降低而特异性升高;年龄较大和曾吸烟与CHP中较低的淋巴细胞百分比相关。
关键数值与推荐
- BALF淋巴细胞百分比>20%诊断CHP的敏感性68.1%、特异性64.8%(基于8项研究的个体患者数据)。
临床怎么用
- BALF淋巴细胞百分比可作为CHP与IPF等间质性肺病鉴别的参考指标,但需注意阈值选择对敏感性和特异性的影响。
局限性
- 原始研究存在纳入偏倚风险,需前瞻性研究评估BALF淋巴细胞百分比对CHP诊断的附加鉴别价值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The role of bronchoalveolar lavage fluid (BALF) lymphocyte percentage in diagnosing chronic hypersensitivity pneumonitis (CHP) is unclear. We conducted a systematic review and meta-analysis of bronchoalveolar lavage (BAL) lymphocyte percentage in the diagnosis of CHP. METHODS: We searched Medline, Embase and the Cochrane Library from inception to August 2019. Individual patient data were obtained to test performance characteristics of BAL lymphocyte percentage at different thresholds. Random-effects models were used for pooled estimates, with comparisons made between CHP and non-CHP interstitial lung diseases (ILDs). RESULTS: Fifty-three studies were included in the systematic review and 42 in the meta-analysis. The pooled estimate for BAL lymphocyte percentage was 42.8% (95% CI 37.7-47.8, I2=95.3%) in CHP, 10.0% (95% CI 6.9-13.1, I2=91.2%) in idiopathic pulmonary fibrosis (IPF), 23.1% (95% CI 3.0-43.2, I2=85.2%) in non-IPF idiopathic interstitial pneumonia (IIP), 23.4% (95% CI 11.0-35.9, I2=45.7%) in connective-tissue disease associated ILD (CTD-ILD) and 31.2% (95% CI 17.6-44.8, I2=95.2%) in sarcoidosis. Results differed between CHP and IPF (p<0.0001), non-IPF IIP (p=0.0309) or CTD-ILD (p=0.0824), but not between CHP and sarcoidosis (p=0.0966). Using individual patient data from eight studies, a lymphocyte percentage threshold of >20% provided a sensitivity of 68.1% and a specificity of 64.8% for CHP. Higher thresholds provided lower sensitivity with higher specificity. Older age and ever having smoked were associated with lower lymphocyte percentage in CHP. CONCLUSIONS: BAL lymphocyte percentage is higher in CHP compared to IPF and other IIPs, with higher thresholds providing improved specificity at the cost of sensitivity. However, the parent studies are at risk of incorporation bias and prospective studies should evaluate the additive discriminate value of BAL lymphocyte percentage to accurately diagnose CHP.
引用
- Adderley N, Humphreys CJ, Barnes H, et al. Bronchoalveolar lavage fluid lymphocytosis in chronic hypersensitivity pneumonitis: a systematic review and meta-analysis. Eur Respir J. 2020. PMID: 32265306. doi:10.1183/13993003.00206-2020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。